Hikma Ventures Archives - Mediformatica

Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures, participated…

Neuralink receives approval to begin clinical trial in Canada on brain implant

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Tag: Hikma Ventures

Octave Bioscience scores $30M for neurodegenerative disease offerings

Prognos Health Raises $23 Million | Healthcare IT Today

Neuralink receives approval to begin clinical trial in Canada on brain implant

A Look at Epic Culture and Interoperability with Brendan Keeler – Part 1

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors – MedCity News

Converge Bio raises $5.5M to expedite drug discovery, development with GenAI

Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? – MedCity News

‘A Lot More Teamwork’: Healthcare Explores the Use of AI for Nursing Workflows

Millions of Americans Still Uninsured or Underinsured Despite ACA Gains

MediFormatica

News Aggregator